Serum level of galectin-9 as a potential biomarker for high risk of malignancy in dermatomyositis.
Shih Y, Chen S, Huang J, Chen Y, Zhu Z, Zhao Q, Zhao X, Xue F, Xiang J, Chen X, Zhu X, Pan M, Wu J, Zheng J, Li H, Cao H.
Shih Y, et al. Among authors: chen s, chen x, chen y.
Rheumatology (Oxford). 2024 Jan 4;63(1):251-258. doi: 10.1093/rheumatology/kead222.
Rheumatology (Oxford). 2024.
PMID: 37184873